VSBC — VITASPRING BIOMEDICAL CO. LTD.
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1697884 ·
Last close
$0.01
Market Cap
—
52W High
$1.00
52W Low
$0.01
ADV30
0
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jul 2026 | 0 | — | -161,817 | -155,817 | 14,822 | 13,367 | 4,677,051 |
| Apr 2026 | 0 | — | -75,844 | -75,844 | 11,432 | 8,167 | 4,517,844 |
| Jan 2026 | 0 | — | -81,464 | -81,464 | 14,676 | 2,084 | 4,445,244 |
| Oct 2025 | 0 | — | -135,733 | -142,518 | 16,465 | 1,960 | 4,365,569 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,182
Investing CF
—
Financing CF
$3,985
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-09-20
Balance + Analyst (yfinance extras)
Retained Earnings
$-5,772,715
Inventory
—
Receivables
$169
ST Investments
—
EBIT TTM
$-392,108
Pretax Income TTM
$-392,108
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jan 2026 | 0 | -385,411 | -415,368 | 14,676 | 4,445,244 | -4,430,568 | -2,688 |
| Jan 2025 | 0 | -679,914 | -774,922 | 14,378 | 4,029,578 | -4,015,200 | -14,675 |
| Jan 2024 | 0 | -1,118,562 | -1,118,562 | 137,342 | 3,487,531 | -3,350,189 | -34,920 |
| Jan 2023 | 0 | -4,177,836 | -4,164,396 | 765,948 | 3,162,440 | -2,396,492 | -77,556 |
| Jan 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$1,790,800
NetIncome TTM
$211,633
OpCashFlow TTM
$0
Assets (Latest)
$3,604,073
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IQV | IQVIA HOLDINGS INC. | $42.50B | $258.21 | — |
| IDXX | IDEXX LABORATORIES INC /DE | $40.84B | $518.39 | — |
| INCY | INCYTE CORP | $23.37B | $115.30 | — |
| MEDP | Medpace Holdings, Inc. | $16.73B | $599.47 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $13.98B | $290.19 | — |
Recent Insider Activity
No insider activity indexed for this ticker.